Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-31

Clinical Trial Update: 99m-Technetium- Glucosamine in Arthritis

View source ↗

Summary

A clinical trial evaluating 99m-Technetium-Glucosamine for rheumatoid arthritis and ankylosing spondylitis is no longer available, indicating the study has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 99m-Technetium-Glucosamine (technetium-99m glucosamine)

Snippet

Sponsor: University of Sydney | Conditions: Rheumatoid Arthritis, Ankylosing Spondylitis | Status: NO_LONGER_AVAILABLE